1-[3-(4-fluorophenyl)-1,2,4-thiadiazol-5-yl]piperazine, 95.0%, 2g

GC capillary column ROTI®Cap-624, 25 m, 0.53 mm, 3.00 µm, 1 Piece(s)

TLC Plates ADAMANT UV254, 10 x 20 cm, 50 Piece(s)

Ethyl 2-ethylacetoacetate, 95.0%, 100g

4,4,5,5-Tetramethyl-2-[4-(4-methylphenyl)phenyl]-1,3,2-dioxaborolane, 97%, 250mg

6-Acrylamidohexanoic Acid>98.0%(T)25g

5-Chloro-2-(chloromethyl)thiazole, 98%, 250mg

3-(Methoxycarbonyl)-5-nitrobenzoic acid, 95.0%, 1kg

N-{[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]methyl}ethanamine hydrochloride, 95.0%, 5g

1-(1-methyl-4-phenylpiperidin-4-yl)methanamine, 95.0%, 1g

(7-isopropyl-5-oxo-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl)acetic acid, 95.0%, 500mg

N-methyl-N-(3-pyridinylmethyl)glycine dihydrochloride, 95.0%, 25g

(S)-2-PHENYLGLYCINOL HCL, 95.0%, 5g